The use of actigraphy in the monitoring of methylphenidate versus placebo in ADHD: A meta-analysis

ADHD Attention Deficit and Hyperactivity Disorders

Volumn 6, Issue 1, 2014, Pages 49-58

  De Crescenzo, Franco ^a,c   Armando, Marco ^a   Mazzone, Luigi ^a   Ciliberto, Mario ^c   Sciannamea, Marco ^d   Figueroa, Caroline ^b   Janiri, Luigi ^c   Quested, Digby ^a   Vicari, Stefano ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c CATHOLIC UNIVERSITY   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Actigraphy; Attention deficit disorder with hyperactivity; Children; Meta analysis; Methylphenidate

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ACTIMETRY; ARTICLE; ATTENTION DEFICIT DISORDER; DRUG DOSE TITRATION; FOLLOW UP; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACTIGRAPHY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; HUMANS; METHYLPHENIDATE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SLEEP;

EID: 84896814118     PISSN: 18666116     EISSN: 18666647     Source Type: Journal    
DOI: 10.1007/s12402-013-0122-x     Document Type: Article

References (55)

1. Antle MC, van Diepen HC, Deboer T, Pedram P, Pereira RR, Meijer JH (2012) Methylphenidate modifies the motion of the circadian clock. Neuropsychopharmacology 37(11): 2446-2455. doi: 10. 1038/npp. 2012. 103.
2. Boonstra AM, Kooij JJ, Oosterlaan J, Sergeant JA, Buitelaar JK, van Someren EJ (2007) Hyperactive night and day? Actigraphy studies in adult ADHD: a baseline comparison and the effect of methylphenidate. Sleep 30(4): 433-442.
3. Castells X, Ramos-Quiroga JA, Bosch R, Nogueira M, Casas M (2011) Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev 6: CD007813. doi: 10. 1002/14651858.
4. Corkum P, Panton R, Ironside S, Macpherson M, Williams T (2008) Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder. J Pediatr Psychol 33(4): 368-379.
5. Cortese S, Faraone SV, Konofal E (2009) Sleep in children with attention-deficit/hyperactivity disorder: meta-analysis of subjective and objective studies. J Am Acad Child Adolesc Psychiatry 48(9): 894-908. doi: 10. 1097/CHI. 0b013e3181ac09c9.
6. Cortese S, Kelly C, Chabernaud C, Proal E, Di Martino A, Milham MP, Castellanos FX (2012) Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies. Am J Psychiatry 169(10): 1038-1055. doi: 10. 1176/appi. ajp. 2012. 11101521.
7. Dalsgaard S (2013) Attention-deficit/hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry 22(Suppl 1): 43-48. doi: 10. 1007/s00787-012-0360-z.
8. Dane AV, Schachar RJ, Tannock R (2000) Does actigraphy differentiate ADHD subtypes in a clinical research setting? J Am Acad Child Adolesc Psychiatry 39(6): 752-760.
9. Faraone SV, Biederman J, Roe C (2002) Comparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysis. J Clin Psychopharmacol 22(5): 468-473.
10. Faraone SV (2012) Understanding the effect size of lisdexamfetamine dimesylate for treating ADHD in children and adults. J Atten Disord 16(2): 128-137. doi: 10. 1177/1087054710379738.
11. Fowler SC, Zarcone TJ, Levant B (2010) Methylphenidate attenuates rats' preference for a novel spatial stimulus introduced into a familiar environment: assessment using a force-plate actometer. J Neurosci Methods 189(1): 36-43. doi: 10. 1016/j. jneumeth. 2010. 03. 014.
12. Frodl T, Skokauskas N (2012) Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects. Acta Psychiatr Scand 125(2): 114-126.
13. Gruber R, Grizenko N, Schwartz G, Ben Amor L, Gauthier J, de Guzman R, Joober R (2006) Sleep and COMT polymorphism in ADHD children: preliminary actigraphic data. J Am Acad Child Adolesc Psychiatry 45(8): 982-989.
14. Gruber R, Grizenko N, Schwartz G, Bellingham J, Guzman R, Joober R (2007) Performance on the continuous performance test in children with ADHD is associated with sleep efficiency. Sleep 30(8): 1003-1009.
15. Hagerman RJ, Murphy MA, Wittenberger MD (1988) A controlled trial of stimulant medication in children with the fragile X syndrome. Am J Med Genet 30(1-2): 377-392.
16. Hanwella R, Senanayake M, de Silva V (2011) Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis. BMC Psychiatry 10(11): 176. doi: 10. 1186/1471-244X-11-176.
17. Hare DJ, Jones S, Evershed K (2006) Objective investigation of the sleep-wake cycle in adults with intellectual disabilities and autistic spectrum disorders. J Intellect Disabil Res 50(Pt 10): 701-710.
18. Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions version 5. 1. 0. The cochrane collaboration. Available from www. cochrane-handbook. org.
19. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414): 557-560.
20. Huang YS, Tsai MH, Guilleminault C (2011) Pharmacological treatment of ADHD and the short and long term effects on sleep. Curr Pharm Des 17(15): 1450-1458.
21. Indic P, Murray G, Maggini C, Amore M, Meschi T, Borghi L, Baldessarini RJ, Salvatore P (2012) Multi-scale motility amplitude associated with suicidal thoughts in major depression. PLoS ONE 7(6): e38761. doi: 10. 1371/journal. pone. 0038761.
22. Ironside S, Davidson F, Corkum P (2010) Circadian motor activity affected by stimulant medication in children with attention-deficit/hyperactivity disorder. J Sleep Res 19(4): 546-551. doi: 10. 1111/j. 1365-2869. 2010. 00845. x.
23. Kam HJ, Lee K, Cho SM et al (2011) High-resolution actigraphic analysis of ADHD: a wide range of movement variability observation in three school courses: a pilot study. Healthc Inform Res 17(1): 29-37.
24. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62(6): 593-602.
25. Kessler RC, Angermeyer M, Anthony JC et al (2007) Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry 6(3): 168-176.
26. Kliegman RM, Stanton B, ST Géme J, Schor N, Behrman E (2011) Nelson textbook of pediatrics, 19th edn. Elsevier Saunders, Philadelphia.
27. Konrad K, Günther T, Heinzel-Gutenbrunner M, Herpertz-Dahlmann B (2005) Clinical evaluation of subjective and objective changes in motor activity and attention in children with attention-deficit/hyperactivity disorder in a double-blind methylphenidate trial. J Child Adolesc Psychopharmacol 15(2): 180-190.
28. Kooij JJ, Middelkoop HA, van Gils K, Buitelaar JK (2001) The effect of stimulants on nocturnal motor activity and sleep quality in adults with ADHD: an open-label case-control study. J Clin Psychiatry 62(12): 952-956.
29. Lahti T, Leppämäki S, Tani P, Partonen T (2009) Actigraphic recording of manic symptoms induced by methylphenidate. Case Rep Med 2009: 286430. doi: 10. 1155/2009/286430.
30. Ludolph AG, Kassubek J, Schmeck K, Glaser C, Wunderlich A, Buck AK, Reske SN, Fegert JM, Mottaghy FM (2008) Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3, 4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study. Neuroimage 41(3): 718-727.
31. Martin JL, Hakim AD (2011) Wrist actigraphy. Chest 139(6): 1514-1527. doi: 10. 1378/chest. 10-1872.
32. Martín-Martínez D, Casaseca-de-la-Higuera P, Alberola-López S, Andrés-de-Llano J, López-Villalobos JA, Ardura-Fernández J, Alberola-López C (2012) Nonlinear analysis of actigraphic signals for the assessment of the attention-deficit/hyperactivity disorder (ADHD). Med Eng Phys 34(9): 1317-1329.
33. Miller LG, Kraft IA (1994) Application of actigraphy in the clinical setting: use in children with attention-deficit hyperactivity disorder. Pharmacotherapy 14(2): 219-223.
34. Mohammadi MR, Mostafavi SA, Keshavarz SA, Eshraghian MR, Hosseinzadeh P, Hosseinzadeh-Attar MJ, Kooshesh SM, Chamari M, Akhondzadeh S (2012) Melatonin effects in methylphenidate treated children with attention deficit hyperactivity disorder: a randomized double blind clinical trial. Iran J Psychiatry 7(2): 87-92.
35. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(6): e1000097. doi: 10. 1371/journal. pmed1000097.
36. Mordre M, Groholt B, Sandstad B, Myhre AM (2012) The impact of ADHD symptoms and global impairment in childhood on working disability in mid-adulthood: a 28-year follow-up study using official disability pension records in a high-risk in-patient population. BMC Psychiatry 19(12): 174. doi: 10. 1186/1471-244X-12-174.
37. Morgenthaler T, Alessi C, Friedman L, Owens J, Kapur V, Boehlecke B, Brown T, Chesson A Jr, Coleman J, Lee-Chiong T, Pancer J, Swick TJ (2007) Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep 30(4): 519-529.
38. Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, Lock TM, Fielbelkorn K, Coles EK, Panahon CJ, Steiner RL, Meichenbaum DL, Onyango AN, Morse GD (2001) Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics 107(6): E105.
39. Ritter PS, Marx C, Lewtschenko N, Pfeiffer S, Leopold K, Bauer M, Pfennig A (2012) The characteristics of sleep in patients with manifest bipolar disorder, subjects at high risk of developing the disease and healthy controls. J Neural Transm 119(10): 1173-1184.
40. Rosa-Neto P, Lou HC, Cumming P, Pryds O, Karrebaek H, Lunding J, Gjedde A (2005) Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. Neuroimage 25(3): 868-876.
41. Sadeh A (2011) The role and validity of actigraphy in sleep medicine: an update. Sleep Med Rev 15(4): 259-267. doi: 10. 1016/j. smrv. 2010. 10. 001.
42. Sangal RB, Owens J, Allen AJ, Sutton V, Schuh K, Kelsey D (2006) Effects of atomoxetine and methylphenidate on sleep in children with ADHD. Sleep 29(12): 1573-1585.
43. Schachter HM, Pham B, King J, Langford S, Moher D (2001) How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ 165(11): 1475-1488.
44. Schwartz G, Amor LB, Grizenko N, Lageix P, Baron C, Boivin DB, Joober R (2004) Actigraphic monitoring during sleep of children with ADHD on methylphenidate and placebo. J Am Acad Child Adolesc Psychiatry 43(10): 1276-1282.
45. Shram MJ, Quinn AM, Chen N, Faulknor J, Luong D, Sellers EM, Endrenyi L (2012) Differences in the in vitro and in vivo pharmacokinetic profiles of once-daily modified-release methylphenidate formulations in Canada: examination of current bioequivalence criteria. Clin Ther 34(5): 1170-1178. doi: 10. 1016/j. clinthera. 2012. 02. 010.
46. Sonuga-Barke EJ, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, Stevenson J, Danckaerts M, van der Oord S, Döpfner M, Dittmann RW, Simonoff E, Zuddas A, Banaschewski T, Buitelaar J, Coghill D, Hollis C, Konofal E, Lecendreux M, Wong IC, Sergeant J (2013) Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry 170(3): 275-289. doi: 10. 1176/appi. ajp. 2012. 12070991.
47. St-Amand J, Provencher MD, Bélanger L, Morin CM (2012) Sleep disturbances in bipolar disorder during remission. J Affect Disord 146(1): 112-119. doi: 10. 1016/j. jad. 2012. 05. 057.
48. Stein MA, Blondis TA, Schnitzler ER, O'Brien T, Fishkin J, Blackwell B, Szumowski E, Roizen NJ (1996) Methylphenidate dosing: twice daily versus three times daily. Pediatrics 98(4 Pt 1): 748-756.
49. Storebø OJ, Gluud C, Winkel P, Simonsen E (2012) Social-skills and parental training plus standard treatment versus standard treatment for children with ADHD: the randomised SOSTRA trial. PLoS ONE 7(6): e37280. doi: 10. 1371/journal. pone. 0037280.
50. Swanson JM, Gupta S, Williams L, Agler D, Lerner M, Wigal S (2002) Efficacy of a new pattern of delivery of methylphenidate for the treatment of ADHD: effects on activity level in the classroom and on the playground. J Am Acad Child Adolesc Psychiatry 41(11): 1306-1314. Erratum in: J Am Acad Child Adolesc Psychiatry 42(2): 260.
51. Taylor E, Döpfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A (2004) European clinical guidelines for hyperkinetic disorder-first upgrade. Eur Child Adolesc Psychiatry 13(Suppl 1): I7-I30.
52. Tirosh E, Sadeh A, Munvez R, Lavie P (1993) Effects of methylphenidate on sleep in children with attention-deficient hyperactivity disorder: an activity monitor study. Am J Dis Child 147(12): 1313-1315.
53. Uebel H, Albrecht B, Kirov R, Heise A, Döpfner M, Freisleder FJ, Gerber WD, Günter M, Hässler F, Ose C, Poustka F, Fischer R, Banaschewski T, Rothenberger A (2010) What can actigraphy add to the concept of labschool design in clinical trials? Curr Pharm Des 16(22): 2434-2442.
54. van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM (2008) Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis. Clin Psychol Rev 28(5): 783-800.
55. van Wyk GW, Hazell PL, Kohn MR, Granger RE, Walton RJ (2012) How oppositionality, inattention, and hyperactivity affect response to atomoxetine versus methylphenidate: a pooled meta-analysis. J Atten Disord 16(4): 314-324. doi: 10. 1177/1087054710389989.